Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is commonly employed, despite the low activity, considering the lack of other effective systemic treatments. In this study, the prognostic and predictive role of soluble immune checkpoints and inflammatory cytokines/chemoki...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ernesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, Anna Acampora, Monica Maria Pagliara, Maria Grazia Sammarco, Maurizio Simmaco, Luana Lionetto, Andrea Botticelli, Emilio Bria, Paolo Marchetti, Maria Antonietta Blasi, Giampaolo Tortora, Giovanni Schinzari, Marianna Nuti
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2022-05-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	uveal melanoma pd-1 soluble checkpoint immunotherapy
Accés en línia:	http://dx.doi.org/10.1080/21645515.2022.2034377
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!